Literature DB >> 2864747

Neurological complications of systemic vasculitis. A report of 2 cases.

A Maloon, V U Fritz, C L Kaplan.   

Abstract

In up to 72% of patients with systemic vasculitis the neurological system may be involved. This may be peripheral or central (brain or spinal cord), and is usually due to infarction or a ruptured aneurysm. Diagnosis and evaluation are based peripherally on examination of a biopsy specimen or centrally on angiography. Therapy is usually with steroids and/or immunosuppressive agents. Two patients with systemic necrotizing vasculitis with unusual neurological complications are presented.

Entities:  

Mesh:

Year:  1985        PMID: 2864747

Source DB:  PubMed          Journal:  S Afr Med J


  5 in total

1.  Subarachnoid haemorrhage as the first clinical manifestation of Churg-Strauss syndrome.

Authors:  Una-Marie Sheerin; Julio Barreto; Martin M Brown; Stefan Brew; Nicholas A Losseff
Journal:  J Neurol       Date:  2008-03-20       Impact factor: 4.849

2.  Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Authors:  Luca Diamanti; Giulia Berzero; Paola Bini; Sabrina Ravaglia; Elisa Rognone; Lorenzo Cavagna; Enrico Marchioni
Journal:  J Neurol       Date:  2013-12-25       Impact factor: 4.849

3.  Subarachnoid haemorrhage as the first clinical manifestation of Churg-Strauss syndrome.

Authors:  U-M Sheerin; J Barreto; M M Brown; S Brew; N A Losseff
Journal:  J Neurol       Date:  2008-05       Impact factor: 4.849

Review 4.  Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature.

Authors:  Shogo Matsuda; Shuzo Yoshida; Youhei Fujiki; Hidetoshi Satomi; Tohru Takeuchi; Yoshinobu Hirose; Shigeki Makino; Shigeki Arawaka
Journal:  Rheumatol Int       Date:  2017-11-10       Impact factor: 2.631

Review 5.  Relapsing subarachnoid hemorrhage as a clinical manifestation in microscopic polyangiitis: a case report and literature review.

Authors:  Jingjing Xie; Ertao Jia; Suli Wang; Ye Yu; Zhiling Li; Jianyong Zhang; Jia Li
Journal:  Clin Rheumatol       Date:  2022-06-11       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.